SCGB1A1 and chronic obstructive pulmonary disease: Serum levels of CC-16, a marker of Clara cell toxicity, are reduced in patients with COPD10, while SP-D is increased in smokers with and without COPD21, and SAA may be a potential biomarker of COPD exacerbation22.